• Ryan Cohlhepp, president and COO, sold 12,500 shares of Bicara Therapeutics common stock on May 15 at a weighted average price of USD 20.29.
• He also exercised stock options for 8,000 shares at USD 3.79 on the same day.
• He ended the day with 191,641 shares of common stock beneficially owned.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicara Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-035937), on May 18, 2026, and is solely responsible for the information contained therein.